 | • レポートコード：GIR-2104Z09123 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、メタボロミクスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メタボロミクスの種類別市場規模（分離技術、検出技術、その他）、用途別市場規模（薬物評価、バイオマーカー発見、ニュートリゲノミクス、臨床毒物学、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・メタボロミクスの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Thermo Fisher Scientific, Inc.、Agilent Technologies, Inc.、Biocrates Life Sciences AG、Shimadzu Corporation、Waters Corporation、Human Metabolome Technologies, Inc.、LECO Corporation、Metabolon, Inc.、Bio-Rad Laboratories, Inc.、Bruker Corporation ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：分離技術、検出技術、その他 ・用途別分析2016年-2026年：薬物評価、バイオマーカー発見、ニュートリゲノミクス、臨床毒物学、その他 ・メタボロミクスの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・メタボロミクスのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・メタボロミクスのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・メタボロミクスの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・メタボロミクスの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Metabolomics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Metabolomics size is estimated to be USD 2017.1 million in 2025 from USD 1347.9 million in 2019, with a change XX% between 2019 and 2020. The global Metabolomics market size is expected to grow at a CAGR of 10.6% for the next five years.
Market segmentation
Metabolomics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Separation Techniques
Detection Techniques
Others
Market segment by Application, can be divided into
Drug Assessment
Biomarker Discovery
Nutrigenomics
Clinical toxicology
Others
Market segment by players, this report covers
Thermo Fisher Scientific, Inc.
Agilent Technologies, Inc.
Biocrates Life Sciences AG
Shimadzu Corporation
Waters Corporation
Human Metabolome Technologies, Inc.
LECO Corporation
Metabolon, Inc.
Bio-Rad Laboratories, Inc.
Bruker Corporation
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Metabolomics
1.2 Classification of Metabolomics by Type
1.2.1 Overview: Global Metabolomics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Metabolomics Revenue Market Share by Type in 2020
1.2.3 Separation Techniques
1.2.4 Detection Techniques
1.2.5 Others
1.3 Global Metabolomics Market by Application
1.3.1 Overview: Global Metabolomics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Drug Assessment
1.3.3 Biomarker Discovery
1.3.4 Nutrigenomics
1.3.5 Clinical toxicology
1.3.6 Others
1.4 Global Metabolomics Market Size & Forecast
1.5 Global Metabolomics Market Size and Forecast by Region
1.5.1 Global Metabolomics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Metabolomics Market Size by Region, (2016-2021)
1.5.3 North America Metabolomics Market Size and Prospect (2016-2026)
1.5.4 Europe Metabolomics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Metabolomics Market Size and Prospect (2016-2026)
1.5.6 South America Metabolomics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Metabolomics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Metabolomics Market Drivers
1.6.2 Metabolomics Market Restraints
1.6.3 Metabolomics Trends Analysis
2 Company Profiles
2.1 Thermo Fisher Scientific, Inc.
2.1.1 Thermo Fisher Scientific, Inc. Details
2.1.2 Thermo Fisher Scientific, Inc. Major Business
2.1.3 Thermo Fisher Scientific, Inc. Metabolomics Product and Solutions
2.1.4 Thermo Fisher Scientific, Inc. Metabolomics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.2 Agilent Technologies, Inc.
2.2.1 Agilent Technologies, Inc. Details
2.2.2 Agilent Technologies, Inc. Major Business
2.2.3 Agilent Technologies, Inc. Metabolomics Product and Solutions
2.2.4 Agilent Technologies, Inc. Metabolomics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.3 Biocrates Life Sciences AG
2.3.1 Biocrates Life Sciences AG Details
2.3.2 Biocrates Life Sciences AG Major Business
2.3.3 Biocrates Life Sciences AG Metabolomics Product and Solutions
2.3.4 Biocrates Life Sciences AG Metabolomics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Biocrates Life Sciences AG Recent Developments and Future Plans
2.4 Shimadzu Corporation
2.4.1 Shimadzu Corporation Details
2.4.2 Shimadzu Corporation Major Business
2.4.3 Shimadzu Corporation Metabolomics Product and Solutions
2.4.4 Shimadzu Corporation Metabolomics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Shimadzu Corporation Recent Developments and Future Plans
2.5 Waters Corporation
2.5.1 Waters Corporation Details
2.5.2 Waters Corporation Major Business
2.5.3 Waters Corporation Metabolomics Product and Solutions
2.5.4 Waters Corporation Metabolomics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Waters Corporation Recent Developments and Future Plans
2.6 Human Metabolome Technologies, Inc.
2.6.1 Human Metabolome Technologies, Inc. Details
2.6.2 Human Metabolome Technologies, Inc. Major Business
2.6.3 Human Metabolome Technologies, Inc. Metabolomics Product and Solutions
2.6.4 Human Metabolome Technologies, Inc. Metabolomics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Human Metabolome Technologies, Inc. Recent Developments and Future Plans
2.7 LECO Corporation
2.7.1 LECO Corporation Details
2.7.2 LECO Corporation Major Business
2.7.3 LECO Corporation Metabolomics Product and Solutions
2.7.4 LECO Corporation Metabolomics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 LECO Corporation Recent Developments and Future Plans
2.8 Metabolon, Inc.
2.8.1 Metabolon, Inc. Details
2.8.2 Metabolon, Inc. Major Business
2.8.3 Metabolon, Inc. Metabolomics Product and Solutions
2.8.4 Metabolon, Inc. Metabolomics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Metabolon, Inc. Recent Developments and Future Plans
2.9 Bio-Rad Laboratories, Inc.
2.9.1 Bio-Rad Laboratories, Inc. Details
2.9.2 Bio-Rad Laboratories, Inc. Major Business
2.9.3 Bio-Rad Laboratories, Inc. Metabolomics Product and Solutions
2.9.4 Bio-Rad Laboratories, Inc. Metabolomics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
2.10 Bruker Corporation
2.10.1 Bruker Corporation Details
2.10.2 Bruker Corporation Major Business
2.10.3 Bruker Corporation Metabolomics Product and Solutions
2.10.4 Bruker Corporation Metabolomics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Bruker Corporation Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Metabolomics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Metabolomics Players Market Share
3.2.2 Top 10 Metabolomics Players Market Share
3.2.3 Market Competition Trend
3.3 Metabolomics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Metabolomics Revenue and Market Share by Type (2016-2021)
4.2 Global Metabolomics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Metabolomics Revenue Market Share by Application (2016-2021)
5.2 Metabolomics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Metabolomics Revenue by Type (2016-2026)
6.2 North America Metabolomics Revenue by Application (2016-2026)
6.3 North America Metabolomics Market Size by Country
6.3.1 North America Metabolomics Revenue by Country (2016-2026)
6.3.2 United States Metabolomics Market Size and Forecast (2016-2026)
6.3.3 Canada Metabolomics Market Size and Forecast (2016-2026)
6.3.4 Mexico Metabolomics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Metabolomics Revenue by Type (2016-2026)
7.2 Europe Metabolomics Revenue by Application (2016-2026)
7.3 Europe Metabolomics Market Size by Country
7.3.1 Europe Metabolomics Revenue by Country (2016-2026)
7.3.2 Germany Metabolomics Market Size and Forecast (2016-2026)
7.3.3 France Metabolomics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Metabolomics Market Size and Forecast (2016-2026)
7.3.5 Russia Metabolomics Market Size and Forecast (2016-2026)
7.3.6 Italy Metabolomics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Metabolomics Revenue by Type (2016-2026)
8.2 Asia-Pacific Metabolomics Revenue by Application (2016-2026)
8.3 Asia-Pacific Metabolomics Market Size by Region
8.3.1 Asia-Pacific Metabolomics Revenue by Region (2016-2026)
8.3.2 China Metabolomics Market Size and Forecast (2016-2026)
8.3.3 Japan Metabolomics Market Size and Forecast (2016-2026)
8.3.4 South Korea Metabolomics Market Size and Forecast (2016-2026)
8.3.5 India Metabolomics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Metabolomics Market Size and Forecast (2016-2026)
8.3.7 Australia Metabolomics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Metabolomics Revenue by Type (2016-2026)
9.2 South America Metabolomics Revenue by Application (2016-2026)
9.3 South America Metabolomics Market Size by Country
9.3.1 South America Metabolomics Revenue by Country (2016-2026)
9.3.2 Brazil Metabolomics Market Size and Forecast (2016-2026)
9.3.3 Argentina Metabolomics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Metabolomics Revenue by Type (2016-2026)
10.2 Middle East & Africa Metabolomics Revenue by Application (2016-2026)
10.3 Middle East & Africa Metabolomics Market Size by Country
10.3.1 Middle East & Africa Metabolomics Revenue by Country (2016-2026)
10.3.2 Turkey Metabolomics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Metabolomics Market Size and Forecast (2016-2026)
10.3.4 UAE Metabolomics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Metabolomics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Metabolomics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Metabolomics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Metabolomics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Metabolomics Revenue Market Share by Region (2021-2026)
Table 6. Thermo Fisher Scientific, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Scientific, Inc. Major Business
Table 8. Thermo Fisher Scientific, Inc. Metabolomics Product and Solutions
Table 9. Thermo Fisher Scientific, Inc. Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Agilent Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Agilent Technologies, Inc. Major Business
Table 12. Agilent Technologies, Inc. Metabolomics Product and Solutions
Table 13. Agilent Technologies, Inc. Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Biocrates Life Sciences AG Corporate Information, Head Office, and Major Competitors
Table 15. Biocrates Life Sciences AG Major Business
Table 16. Biocrates Life Sciences AG Metabolomics Product and Solutions
Table 17. Biocrates Life Sciences AG Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Shimadzu Corporation Corporate Information, Head Office, and Major Competitors
Table 19. Shimadzu Corporation Major Business
Table 20. Shimadzu Corporation Metabolomics Product and Solutions
Table 21. Shimadzu Corporation Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Waters Corporation Corporate Information, Head Office, and Major Competitors
Table 23. Waters Corporation Major Business
Table 24. Waters Corporation Metabolomics Product and Solutions
Table 25. Waters Corporation Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Human Metabolome Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Human Metabolome Technologies, Inc. Major Business
Table 28. Human Metabolome Technologies, Inc. Metabolomics Product and Solutions
Table 29. Human Metabolome Technologies, Inc. Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. LECO Corporation Corporate Information, Head Office, and Major Competitors
Table 31. LECO Corporation Major Business
Table 32. LECO Corporation Metabolomics Product and Solutions
Table 33. LECO Corporation Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Metabolon, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Metabolon, Inc. Major Business
Table 36. Metabolon, Inc. Metabolomics Product and Solutions
Table 37. Metabolon, Inc. Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Bio-Rad Laboratories, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Bio-Rad Laboratories, Inc. Major Business
Table 40. Bio-Rad Laboratories, Inc. Metabolomics Product and Solutions
Table 41. Bio-Rad Laboratories, Inc. Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Bruker Corporation Corporate Information, Head Office, and Major Competitors
Table 43. Bruker Corporation Major Business
Table 44. Bruker Corporation Metabolomics Product and Solutions
Table 45. Bruker Corporation Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Metabolomics Revenue (USD Million) by Players (2019-2021)
Table 47. Global Metabolomics Revenue Share by Players (2019-2021)
Table 48. Breakdown of Metabolomics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Metabolomics Players Head Office, Products and Services Provided
Table 50. Metabolomics Mergers & Acquisitions in the Past Five Years
Table 51. Metabolomics New Entrants and Expansion Plans
Table 52. Global Metabolomics Revenue (USD Million) by Type (2016-2021)
Table 53. Global Metabolomics Revenue Share by Type (2016-2021)
Table 54. Global Metabolomics Revenue Forecast by Type (2021-2026)
Table 55. Global Metabolomics Revenue by Application (2016-2021)
Table 56. Global Metabolomics Revenue Forecast by Application (2021-2026)
Table 57. North America Metabolomics Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Metabolomics Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Metabolomics Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Metabolomics Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Metabolomics Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Metabolomics Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Metabolomics Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Metabolomics Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Metabolomics Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Metabolomics Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Metabolomics Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Metabolomics Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Metabolomics Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Metabolomics Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Metabolomics Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Metabolomics Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Metabolomics Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Metabolomics Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Metabolomics Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Metabolomics Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Metabolomics Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Metabolomics Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Metabolomics Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Metabolomics Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Metabolomics Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Metabolomics Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Metabolomics Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Metabolomics Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Metabolomics Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Metabolomics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Metabolomics Picture
Figure 2. Global Metabolomics Revenue Market Share by Type in 2020
Figure 3. Separation Techniques
Figure 4. Detection Techniques
Figure 5. Others
Figure 6. Metabolomics Revenue Market Share by Application in 2020
Figure 7. Drug Assessment Picture
Figure 8. Biomarker Discovery Picture
Figure 9. Nutrigenomics Picture
Figure 10. Clinical toxicology Picture
Figure 11. Others Picture
Figure 12. Global Metabolomics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Metabolomics Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Metabolomics Revenue Market Share by Region (2016-2026)
Figure 15. Global Metabolomics Revenue Market Share by Region in 2020
Figure 16. North America Metabolomics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Metabolomics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Metabolomics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Metabolomics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Metabolomics Market Drivers
Figure 21. Metabolomics Market Restraints
Figure 22. Metabolomics Market Trends
Figure 23. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
Figure 24. Agilent Technologies, Inc. Recent Developments and Future Plans
Figure 25. Biocrates Life Sciences AG Recent Developments and Future Plans
Figure 26. Shimadzu Corporation Recent Developments and Future Plans
Figure 27. Waters Corporation Recent Developments and Future Plans
Figure 28. Human Metabolome Technologies, Inc. Recent Developments and Future Plans
Figure 29. LECO Corporation Recent Developments and Future Plans
Figure 30. Metabolon, Inc. Recent Developments and Future Plans
Figure 31. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
Figure 32. Bruker Corporation Recent Developments and Future Plans
Figure 34. Global Metabolomics Revenue Share by Players in 2020
Figure 35. Metabolomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Metabolomics Revenue Market Share in 2020
Figure 37. Global Top 10 Players Metabolomics Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Metabolomics Revenue Share by Type in 2020
Figure 40. Global Metabolomics Market Share Forecast by Type (2021-2026)
Figure 41. Global Metabolomics Revenue Share by Application in 2020
Figure 42. Global Metabolomics Market Share Forecast by Application (2021-2026)
Figure 43. North America Metabolomics Sales Market Share by Type (2016-2026)
Figure 44. North America Metabolomics Sales Market Share by Application (2016-2026)
Figure 45. North America Metabolomics Revenue Market Share by Country (2016-2026)
Figure 46. United States Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Metabolomics Sales Market Share by Type (2016-2026)
Figure 50. Europe Metabolomics Sales Market Share by Application (2016-2026)
Figure 51. Europe Metabolomics Revenue Market Share by Country (2016-2026)
Figure 52. Germany Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Metabolomics Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Metabolomics Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Metabolomics Revenue Market Share by Region (2016-2026)
Figure 60. China Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Metabolomics Sales Market Share by Type (2016-2026)
Figure 67. South America Metabolomics Sales Market Share by Application (2016-2026)
Figure 68. South America Metabolomics Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Metabolomics Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Metabolomics Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Metabolomics Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Metabolomics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のメタボロミクスバイオマーカー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Metabolomics Biomarker Market The global Metabolomics Biomarker market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the repo…- 世界のゲノム編集技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Genome Editing Techniques Market The global Genome Editing Techniques market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, th…
- 世界のバイオインフォマティクスサービス市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bioinformatics Services Market The global Bioinformatics Services market size is projected to reach US$ 2694.9 million by 2026, from US$ 1364.6 million in 2019, at a CAGR of 10.1% during 2021-2026. With industry-standard accuracy in analysis and high data integri…
- 世界のバイオインフォマティクス市場規模・現状・予測（2021年-2027年） Bioinformatics is an interdisciplinary field that develops methods and software tools for understanding biological data. As an interdisciplinary field of science, bioinformatics combines biology, computer science, mathematics and statistics to analyze and interpret biological data. Bioinformatics ha…
- 世界のマルチプレックス検出イムノアッセイ市場規模・現状・予測（2021年-2027年） Multiplex immunoassay development is ascribed to the expanding requirement for enhanced disease analytic procedures alongside the diminished costs and minimized errors. Growth of the global multiplex detection immunoassay market is expected to rise due to expanding geriatric population inclined to i…